Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Menlo Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-17Dec-31-16Dec-31-15
Revenues4.60.70.0
            Revenue growth579.8%  
Cost of goods sold0.00.00.0
Gross profit4.60.70.0
            Gross margin100.0%100.0% 
Research and development29.011.32.9
General and administrative5.23.81.7
EBIT-29.6-14.3-4.6
            EBIT margin-645.9%-2126.4% 
Pre-tax income-29.1-14.1-4.6
Income taxes0.00.00.0
            Tax rate0.0%0.0%0.0%
Net income-29.1-14.1-4.6
            Net margin-634.6%-2087.2% 
 
Diluted EPS($5.69)($2.82)($0.97)
Shares outstanding (diluted)5.15.04.7
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2018 | Contact Us | Data Disclaimer | Terms of Use | Privacy